Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lisa Durrant

ARCII: A Phase II Trial of the HIV Protease Inhibitor Nelfinavir in Combination With Chemoradiation for Locally Advanced Inoperable Pancreatic Cancer

Radiotherapy and Oncology

English

Oxygen-Enhanced MRI MOLLI T1 Mapping During Chemoradiotherapy in Anal Squamous Cell Carcinoma

Clinical and Translational Radiation Oncology

English

Related publications

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently With Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Effect of Adding mFOLFOX6 After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Multicentre, Phase 2 Trial

The Lancet Oncology

Oncology

2015

English

Phase I Trial of Vorinostat Added to Chemoradiation With Capecitabine in Pancreatic Cancer

Radiotherapy and Oncology

English

Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer

Clinical Cancer Research

Cancer Research

Oncology

2015

English

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer

Journal of immunotherapy (Hagerstown, Md. : 1997)

English

Multiagent Induction Chemotherapy Followed by Chemoradiation Is Associated With Improved Survival in Locally Advanced Pancreatic Cancer

English

Final Analysis of a Phase II Study of Modified FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer

British Journal of Cancer

Cancer Research

Oncology

2016

English

Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1997

English

Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer

International Journal of Radiation Oncology Biology Physics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lisa Durrant

ARCII: A Phase II Trial of the HIV Protease Inhibitor Nelfinavir in Combination With Chemoradiation for Locally Advanced Inoperable Pancreatic Cancer

Oxygen-Enhanced MRI MOLLI T1 Mapping During Chemoradiotherapy in Anal Squamous Cell Carcinoma

Related publications

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently With Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Effect of Adding mFOLFOX6 After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Multicentre, Phase 2 Trial

Phase I Trial of Vorinostat Added to Chemoradiation With Capecitabine in Pancreatic Cancer

Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine for Patients With Advanced Pancreatic Cancer

Multiagent Induction Chemotherapy Followed by Chemoradiation Is Associated With Improved Survival in Locally Advanced Pancreatic Cancer

Final Analysis of a Phase II Study of Modified FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer

Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.

Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer